tiprankstipranks
Advertisement
Advertisement

JP:130A Stock Latest News

Veritas In Silico Expands mRNA Partnerships as ALS Drug and Delivery Pipeline Advance
Company AnnouncementsVeritas In Silico Expands mRNA Partnerships as ALS Drug and Delivery Pipeline Advance
1M ago
130A
Veritas In Silico Widens Losses as Revenue Slips and Equity Declines
PremiumCompany Announcements
Veritas In Silico Widens Losses as Revenue Slips and Equity Declines
1M ago
130A
Veritas In Silico and MGC File First-in-Class lncRNA Cancer Drug Patent
PremiumCompany Announcements
Veritas In Silico and MGC File First-in-Class lncRNA Cancer Drug Patent
1M ago
130A
Veritas In Silico Reshapes Research Leadership With Executive Officer Change
PremiumCompany Announcements
Veritas In Silico Reshapes Research Leadership With Executive Officer Change
2M ago
130A
Veritas In Silico and SpiroChem Sign Joint Pact on Next-Generation mRNA Drugs
PremiumCompany Announcements
Veritas In Silico and SpiroChem Sign Joint Pact on Next-Generation mRNA Drugs
4M ago
130A
Veritas In Silico Deepens mRNA Drug Partnerships as Loss Widens in Q1 FY2026
PremiumCompany AnnouncementsVeritas In Silico Deepens mRNA Drug Partnerships as Loss Widens in Q1 FY2026
4M ago
130A
Veritas In Silico Books ¥135 Million Impairment, Keeps 2026 Outlook Intact
Premium
Company Announcements
Veritas In Silico Books ¥135 Million Impairment, Keeps 2026 Outlook Intact
4M ago
130A
Veritas In Silico Widens Quarterly Losses but Keeps 2026 Outlook Unchanged
Premium
Company Announcements
Veritas In Silico Widens Quarterly Losses but Keeps 2026 Outlook Unchanged
4M ago
130A
Veritas In Silico Ends mRNA Drug Discovery Collaboration with Takeda
PremiumCompany Announcements
Veritas In Silico Ends mRNA Drug Discovery Collaboration with Takeda
5M ago
130A
Veritas In Silico Revamps Board and Audit Lineup Ahead of 10th AGM
PremiumCompany Announcements
Veritas In Silico Revamps Board and Audit Lineup Ahead of 10th AGM
7M ago
130A
Veritas In Silico Unveils AI-Driven Strategy to Become Specialty Pharma Leader
PremiumCompany Announcements
Veritas In Silico Unveils AI-Driven Strategy to Become Specialty Pharma Leader
7M ago
130A
Veritas In Silico Issues Fiscal 2025 Results With Caution on Forward-Looking Statements
PremiumCompany Announcements
Veritas In Silico Issues Fiscal 2025 Results With Caution on Forward-Looking Statements
7M ago
130A
Veritas In Silico Widens Losses but Targets Revenue Rebound in 2026
PremiumCompany AnnouncementsVeritas In Silico Widens Losses but Targets Revenue Rebound in 2026
7M ago
130A
Veritas In Silico and SpiroChem Forge AI-Driven Alliance on Next-Generation RNA-Binding Drugs
Premium
Company Announcements
Veritas In Silico and SpiroChem Forge AI-Driven Alliance on Next-Generation RNA-Binding Drugs
7M ago
130A
Veritas In Silico and Jikei University Secure Patent Publication for Novel ALS Nucleic Acid Therapy
Premium
Company Announcements
Veritas In Silico and Jikei University Secure Patent Publication for Novel ALS Nucleic Acid Therapy
8M ago
130A
Veritas In Silico Files Patent for First-in-Class mRNA-Targeted Drug for Post-Surgery Kidney Injury
PremiumCompany Announcements
Veritas In Silico Files Patent for First-in-Class mRNA-Targeted Drug for Post-Surgery Kidney Injury
9M ago
130A
Veritas In Silico’s Strategic Shift Towards Specialty Pharma
PremiumCompany Announcements
Veritas In Silico’s Strategic Shift Towards Specialty Pharma
9M ago
130A
Veritas In Silico Secures Patent for Innovative Drug Delivery System
PremiumCompany Announcements
Veritas In Silico Secures Patent for Innovative Drug Delivery System
9M ago
130A
Veritas In Silico Partners with Shimane University for Post-Transplant Drug Development
PremiumCompany Announcements
Veritas In Silico Partners with Shimane University for Post-Transplant Drug Development
10M ago
130A
Veritas In Silico Inc. Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsVeritas In Silico Inc. Reports Q3 2025 Financial Results
10M ago
130A
Veritas In Silico Inc. Reports Significant Financial Decline
Premium
Company Announcements
Veritas In Silico Inc. Reports Significant Financial Decline
10M ago
130A
Veritas In Silico Reports Declining Financial Performance for 2025
Premium
Company Announcements
Veritas In Silico Reports Declining Financial Performance for 2025
10M ago
130A

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >